A team of engineers from Apple Inc. working with researchers from several institutions in the U.S. has found that smartwatches
Continue reading »Home »
Researchers aim to advance understanding of Alzheimer’s disease progression
University of Maryland (UMD) and U.S. Food and Drug Administration (FDA) researchers are working together to develop a new X-ray
Continue reading »Suppression of newly found protein could lead to future treatments to slow Alzheimer’s progression
Researchers at the Case Western University School of Medicine say they have identified a previously unknown gene and associated protein
Continue reading »Home-based tools can help assess dementia risk and progression
Clinical trials to develop new therapeutic and preventive treatments for Alzheimer’s disease (AD) are costly, complicated and often preclude persons
Continue reading »Neighborhood-level socioeconomics tied to MS disability progression
(HealthDay)—Lower neighborhood-level socioeconomic status (SES) is associated with a higher risk for disability progression in patients with multiple sclerosis (MS),
Continue reading »Genomic study finds a new role for microRNAs as predictors of Crohn’s disease progression
Crohn’s disease is a lifelong condition characterized by a fluctuating course of gastro-intestinal inflammation with repeated flares and remissions. Any
Continue reading »A molecular key for delaying the progression of multiple sclerosis is found
Multiple sclerosis (MS) is an autoimmune disease that attacks and destroys the myelin sheath that insulates nerve cells. Current treatment
Continue reading »Deep brain stimulation ‘slows Parkinson’s progression’
Parkinson’s disease is a neurodegenerative condition that affects an estimated 500,000 people in the United States. As the condition mostly
Continue reading »Dynamics of brain volume loss vary with MS progression
(HealthDay)—Brain volume loss (BVL) has nonlinear dynamics and limited reproducibility as a marker of therapeutic response in multiple sclerosis (MS),
Continue reading »